Drug intelligence / Profile preview

Chuansouning Pian

Development stage: Unknown
Lead developer: Shaanxi Momentum Pharmaceutical
Administration: Oral

Overview

Chuansouning Pian (川搜宁片) is a Traditional Chinese Medicine (TCM) herbal formulation developed and marketed by Shaanxi Momentum Qixuehe Pharmaceutical Co., Ltd. It is an oral tablet indicated for the treatment of various respiratory conditions, including bronchial asthma, asthmatic bronchitis, pulmonary emphysema, and early-stage pulmonary heart disease. In the context of Traditional Chinese Medicine, its therapeutic action is described as clearing heat to relieve dyspnea and tranquilizing cough to resolve phlegm. The product is currently approved and marketed in China, where it is manufactured by a high-tech TCM enterprise founded in 1995.

Brand names: Chuansouning Pian
Other names: Chuansouning Tablet川搜宁片

Beyond the preview

Go deeper on Chuansouning Pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chuansouning Pian.

Explore the full profile